IPHA
Price
$2.12
Change
+$0.09 (+4.43%)
Updated
Oct 15, 11:03 AM (EDT)
Capitalization
179.64M
28 days until earnings call
Intraday Buy/Sell Signals
VALN
Price
$10.44
Change
+$0.03 (+0.29%)
Updated
Oct 15, 11:08 AM (EDT)
Capitalization
897.37M
28 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

IPHA vs VALN

Header iconIPHA vs VALN Comparison
Open Charts IPHA vs VALNBanner chart's image
Innate Pharma SA
Price$2.12
Change+$0.09 (+4.43%)
Volume$2.42K
Capitalization179.64M
Valneva SE
Price$10.44
Change+$0.03 (+0.29%)
Volume$100
Capitalization897.37M
IPHA vs VALN Comparison Chart in %
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VALN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPHA vs. VALN commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPHA is a Hold and VALN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (IPHA: $2.03 vs. VALN: $10.40)
Brand notoriety: IPHA and VALN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPHA: 150% vs. VALN: 71%
Market capitalization -- IPHA: $179.64M vs. VALN: $897.37M
IPHA [@Biotechnology] is valued at $179.64M. VALN’s [@Biotechnology] market capitalization is $897.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPHA’s FA Score shows that 1 FA rating(s) are green whileVALN’s FA Score has 1 green FA rating(s).

  • IPHA’s FA Score: 1 green, 4 red.
  • VALN’s FA Score: 1 green, 4 red.
According to our system of comparison, VALN is a better buy in the long-term than IPHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPHA’s TA Score shows that 5 TA indicator(s) are bullish while VALN’s TA Score has 3 bullish TA indicator(s).

  • IPHA’s TA Score: 5 bullish, 5 bearish.
  • VALN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IPHA is a better buy in the short-term than VALN.

Price Growth

IPHA (@Biotechnology) experienced а +4.10% price change this week, while VALN (@Biotechnology) price change was -2.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.44%. For the same industry, the average monthly price growth was +17.42%, and the average quarterly price growth was +81.94%.

Reported Earning Dates

IPHA is expected to report earnings on Nov 13, 2025.

VALN is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VALN($897M) has a higher market cap than IPHA($180M). VALN YTD gains are higher at: 137.992 vs. IPHA (10.326).
IPHAVALNIPHA / VALN
Capitalization180M897M20%
EBITDAN/A-20.38M-
Gain YTD10.326137.9927%
P/E RatioN/AN/A-
RevenueN/A196M-
Total CashN/A161M-
Total DebtN/A197M-
FUNDAMENTALS RATINGS
IPHA: Fundamental Ratings
IPHA
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
32
SEASONALITY SCORE
1..100
10

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IPHAVALN
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 8 days ago
73%
Bullish Trend 8 days ago
74%
Declines
ODDS (%)
Bearish Trend 10 days ago
83%
Bearish Trend 10 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
Aroon
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VALN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PSYCF0.01N/A
+5.60%
Psyched Wellness Ltd.
QBEIF13.71N/A
N/A
QBE Insurance Group Ltd.
UNLRY2.06N/A
N/A
PT Unilever Indonesia Tbk
RPGHF1.69N/A
N/A
RPMGLOBAL HLDGS LTD.
ACCMF10.75-0.30
-2.71%
AAC CLYDE SPACE AB

IPHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHA has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHA jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHA
1D Price
Change %
IPHA100%
+2.53%
MDGL - IPHA
43%
Loosely correlated
+2.19%
APLM - IPHA
36%
Loosely correlated
N/A
SLNO - IPHA
34%
Loosely correlated
-1.07%
VALN - IPHA
30%
Poorly correlated
-0.90%
TNXP - IPHA
30%
Poorly correlated
-0.25%
More

VALN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VALN has been loosely correlated with INRLF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VALN jumps, then INRLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VALN
1D Price
Change %
VALN100%
-0.90%
INRLF - VALN
42%
Loosely correlated
N/A
IMTX - VALN
33%
Loosely correlated
+0.85%
PTCT - VALN
32%
Poorly correlated
+0.05%
BMRN - VALN
32%
Poorly correlated
+0.04%
IPHA - VALN
32%
Poorly correlated
+2.53%
More